BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

(2009) Grace M Callagy et al.   BMC CANCER

Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer

(2009) Douglas G. Altman   CANCER INVESTIGATION

Putting Risk Prediction in Perspective: Relative Utility Curves

(2009) Stuart G. Baker   JNCI-Journal of the National Cancer Institute

Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

(2008) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Application of the 70-Gene Profile: The MINDACT Trial

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY